A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis. [electronic resource]
Producer: 20160920Description: 1722-1733 p. digitalISSN:- 1525-0024
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Proliferation
- Humans
- Immunoglobulin Fc Fragments -- pharmacology
- MCF-7 Cells
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasms -- drug therapy
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction
- Trastuzumab -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.